Category: Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval

Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval

  1. Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval  Zacks.com
  2. What Adamas FDA Approval Really Means  Seeking Alpha
  3. This Biotech Rose To A 19-Month High — What’s Prodding Shares?  Investor’s Business Daily
  4. Full coverage

from Business – Google News https://www.zacks.com/stock/news/273430/adamas-pharmaceuticals-adms-stock-soars-41-after-fda-approval

Advertisements

Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval

  1. Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval  Nasdaq
  2. Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers  TheStreet.com
  3. ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB’s Humira Biosim  Markets Insider
  4. Full coverage

from Business – Google News http://www.nasdaq.com/article/adamas-pharmaceuticals-adms-stock-soars-41-after-fda-approval-cm837456

Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval

  1. Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval  Zacks.com
  2. Adamas Skyrockets on FDA Approval for Dyskinesia Treatment – Biotech Movers  TheStreet.com
  3. What Adamas FDA Approval Really Means  Seeking Alpha
  4. Full coverage

from Business – Google News https://www.zacks.com/stock/news/273430/adamas-pharmaceuticals-adms-stock-soars-41-after-fda-approval

Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval

  1. Adamas Pharmaceuticals (ADMS) Stock Soars 41% After FDA Approval  Zacks.com
  2. This Biotech Rose To A 19-Month High — What’s Prodding Shares?  Investor’s Business Daily
  3. Adamas Pharma’s Gocovri Approved, A Welcome Addition To Parkinson’s Treatments  Benzinga
  4. Full coverage

from Business – Google News https://www.zacks.com/stock/news/273430/adamas-pharmaceuticals-adms-stock-soars-41-after-fda-approval